Product Name

  • Name

    SANGIVAMYCIN

  • EINECS
  • CAS No. 18417-89-5
  • Article Data11
  • CAS DataBase
  • Density 1.3120 (rough estimate)
  • Solubility
  • Melting Point 260°C
  • Formula C12H15N5O5
  • Boiling Point 880.6°C at 760 mmHg
  • Molecular Weight 309.32
  • Flash Point 486.4°C
  • Transport Information
  • Appearance
  • Safety Poison by ingestion, intravenous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
  • Risk Codes R26/27/28
  • Molecular Structure Molecular Structure of 18417-89-5 (SANGIVAMYCIN)
  • Hazard Symbols T+
  • Synonyms 7-DEAZA-7-CARBAMOYLADENOSINE;7-Carboxamido-7-deazaadenosine;7-DEAZAADENOSINE-7-CARBOXAMIDE;SANGIVAMYCIN;
  • PSA 178.97000
  • LogP -1.05890

Sangivamycin Chemical Properties

Empirical Formula of Sangivamycin (CAS NO.18417-89-5): C12H15N5O5
Molecular Weight: 309.278 g/mol
Index of Refraction: 1.886
Density: 2.06 g/cm3
Flash Point: 443.9 °C
Enthalpy of Vaporization: 123.52 kJ/mol
Boiling Point: 810.4 °C at 760 mmHg
Vapour Pressure: 9.5E-28 mmHg at 25 °C
Structure of Sangivamycin (CAS NO.18417-89-5):
                       
IUPAC Name: 4-Amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide
Canonical SMILES: C1=C(C2=C(N1C3C(C(C(O3)CO)O)O)N=CN=C2N)C(=O)N
Isomeric SMILES: C1=C(C2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=CN=C2N)C(=O)N
InChI: InChI=1S/C12H15N5O5/c13-9-6-4(10(14)21)1-17(11(6)16-3-15-9)12-8(20)7(19)5(2-18)22-12/h1,3,5,7-8,12,18-20H,2H2,(H2,14,21)(H2,13,15,16)/t5-,7-,8-,12-/m1/s1
InChIKey: OBZJZDHRXBKKTJ-JTFADIMSSA-N

Sangivamycin Toxicity Data With Reference

1.    

dni-hmn:hla 20 mg/L

    JANTAJ    Journal of Antibiotics. 35 (1982),119.
2.    

oms-hmn:hla 20 mg/L

    JANTAJ    Journal of Antibiotics. 35 (1982),119.
3.    

oms-mus:leu 10 µmol/L

    BCPCA6    Biochemical Pharmacology. 29 (1980),305.
4.    

ipr-rat LDLo:1200 µg/kg

    NCINS*    National Cancer Institute Report .(Bethesda, MD.: )1967,269.
5.    

orl-mus LD50:11 mg/kg

    NCISP*    National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 .
6.    

ipr-mus LDLo:4 mg/kg

    NCINS*    National Cancer Institute Report .(Bethesda, MD.: )1967,269.
7.    

ivn-mus LD50:5 mg/kg

    85GDA2    CRC Handbook of Antibiotic Compounds, Volumes 1-9. 5 (1981),313.

Sangivamycin Safety Profile

Poison by ingestion, intravenous and intraperitoneal routes. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes of Sangivamycin (CAS NO.18417-89-5): VeryT+
Risk Statements: 26/27/28 
R26/27/28:Very toxic by inhalation, in contact with skin and if swallowed.
Safety Statements: 36/37/39-45 
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection. 
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)

Sangivamycin Specification

 Sangivamycin , its cas register number is 18417-89-5. It also can be called Ara-sangivamycin ; 4-Amino-7-beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine-5-carboxamide ; and 7H-Pyrrolo(2,3-d)pyrimidine-5-carboxamide, 4-amino-7-beta-D-ribofuranosyl- .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View